A randomized, double‐dummy, parallel group, multicenter trial comparing the efficacy and safety of UMEC/VI (a fixed combination of umeclidinium and vilanterol) with tiotropium in subjects with COPD who continue to have symptoms on tiotropium

Authors
Category Primary study
Year 2017
This article has no abstract
Epistemonikos ID: 25556200b37469781083f25ceba2731cae42edf5
First added on: Sep 03, 2019